Market Closed –
|
5-day change | 1st Jan Change | ||
17.64 AUD |
-0.28% | -1.29% | +16.98% |
Published on 05/26/2025 at 18:35

© Reuters – 2025
Jarden Research Downgrades ALS to Underweight from Neutral, Adjusts Price Target to AU$15 from AU$14.50 |
May. 23 |
MT |
ALS Sees Underlying Profit of Up to AU$313 Million in Fiscal 2025, No Direct Impact From US Policies; Shares Up 3% |
Apr. 27 |
MT |
Als Reports No Material Impact On Input Costs From Tariffs |
Apr. 27 |
RE |
ALS Limited Announces Appointment of Catharine Farrow as an Independent Non-Executive Director, Effective 24 March 2025 |
Mar. 02 |
CI |
ALS Set for Potential Upside to Earnings Outlook, Jarden Research Says |
Nov. 20 |
MT |
Jarden Downgrades ALS to Neutral from Overweight, Adjusts Price Target to AU$14.40 from AU$14.25 |
Nov. 20 |
MT |
ALS Limited, H1 2025 Earnings Call, Nov 19, 2024 |
Nov. 18 |
|
ALS Limited Reports Earnings Results for the Half Year Ended September 30, 2024 |
Nov. 18 |
CI |
Chilwa Minerals Expects Separation Lab in Malawi to be Fully Operational in Four Weeks |
24-10-20 |
MT |
ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024 |
24-09-24 |
CI |
ALS Geochemistry Business Volumes Deteriorating, But Life Sciences Unit Remains Resilient, Says Jarden Research |
24-09-22 |
MT |
Jarden Research Adjusts ALS’ Price Target to AU$14.20 from AU$14.90; Keeps at Overweight |
24-09-20 |
MT |
ALS Expects Net Profit to Fall 5% in Fiscal H1 |
24-09-18 |
MT |
ALS Limited’s Equity Buyback announced on July 25, 2022 has expired. |
24-08-26 |
CI |
ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel |
24-08-12 |
CI |
ALS Limited – Shareholder/Analyst Call |
24-07-30 |
|
ALS Unit Served Federal Court Proceedings in Alleged Coal Shipment Discrepancies |
24-07-25 |
MT |
UBS Upgrades ALS Limited to Buy From Neutral; Price Target is AU$17 |
24-07-22 |
MT |
ALS Completes Acquisition of Wessling Holding |
24-06-04 |
MT |
ALS Limited acquired Wessling Holding Gmbh & Co.Kg. |
24-05-30 |
CI |
Jarden Downgrades ALS to Overweight From Buy, Adjusts Price Target to AU$14.90 From AU$13.70 |
24-05-21 |
MT |
Als Limited Provides Earnings Guidance for 2024 |
24-05-20 |
CI |
ALS Limited, 2024 Earnings Call, May 21, 2024 |
24-05-20 |
|
ALS Limited Reports Earnings Results for the Full Year Ended March 31, 2024 |
24-05-20 |
CI |
Morgans Financial Downgrades ALS to Hold from Add, Price Target at AU$13.70 |
24-04-01 |
MT |
ALQ: Dynamic Chart
ALS Limited is an Australia-based company engaged in the provision of professional technical services, primarily in the areas of testing, measurement and inspection. The Company provides comprehensive testing solutions to clients in a range of industries around the world. The Company operates through two segments: Commodities and Life Sciences. Its Commodities segment provides assaying and analytical testing services and metallurgical services for mining and mineral exploration companies and provides specialist services to the coal industry, such as coal sampling, analysis and certification, formation evaluation services, tribology testing services and related analytical testing. The Life Sciences segment provides analytical testing data to assist consulting and engineering firms, industry, and governments around the world in making informed decisions about environmental, food and pharmaceutical, electronics, consumer products, and animal health.
More about the company

Buy
Average target price
17.02AUD
Spread / Average Target
-3.51%
Consensus
Quarterly revenue – Rate of surprise
Select your edition
All financial news and data tailored to specific country editions